Friday 22 September 2017

Faculté de Pharmacie
3, rue du Professeur Laguesse
BP83 - 59006 - Lille Cedex
Tél. : +33 (0)3 20 96 40 40
Fax : +33 (0)3 20 95 90 09

Prof. Dr. Juergen SIEPMANN

Université Lille Nord de France
College of Pharmacy
3, rue du Professeur Laguesse
59006 Lille, France

Tel:  +33-3-
Fax: +33-3-
Télécharger le fichierjuergen.siepmann(at)

Short CV

Juergen Siepmann studied pharmacy and did his Ph.D. at the Freie Universitaet Berlin, Germany. Since 2004 he is Professor of Pharmaceutical Technology at the University of Lille, France. His awards include the “APV-Prize for the outstanding doctoral thesis in Pharmaceutical Sciences from the years 1998/99”, a Marie Curie Individual Post-Doctoral Fellowship and the “2012 APV Research Award for Outstanding Achievements in the Pharmaceutical Sciences”. He was visiting scientist/postdoctoral fellow at Purdue University, the University of Paris-Sud, the University of Iowa and the University of Angers.

Prof. Siepmann’s research focuses on controlled drug delivery systems, in particular on the elucidation of the underlying mass transport phenomena and the optimization of the devices. So far, he published his work in more than 150 articles in international scientific journals, 250 poster and 100 oral presentations at national and international scientific meetings. He is editor of 3 books and author of 16 book chapters.

Since 2010 Prof. Siepmann is heading the INSERM research group “Controlled Drug Delivery Systems and Biomaterials” (about 7 professors, 5 lecturers, 5 technical/administrative staff, 15 post-docs & PhD students and 10 master students). In 2015, Prof. Siepmann served as Editor-in-Chief of the "Journal of Drug Delivery Sciences and Technology", since 2016 he is Editor-in-Chief of the “International Journal of Pharmaceutics”. Since 2010 he serves as president of the APGI (“International Society of Drug Delivery Sciences and Technology”).


Main research interests

  • Preparation and physicochemical characterization of controlled drug delivery systems

  • Elucidation of the underlying drug release mechanisms from controlled drug delivery systems

  • Optimization of drug concentrations at the site of action in order to improve the efficacy of the therapeutical treatment and to minimize adverse effects

Page updated on 30/08/2016 (09h29)
Flux rss actualités